Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diabetes exacerbates brain pathology following a focal blast brain injury: New role of a multimodal drug cerebrolysin and nanomedicine.
Muresanu DF, Sharma A, Sahib S, Tian ZR, Feng L, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Sjöquist PO, Patnaik R, Wiklund L, Sharma HS. Muresanu DF, et al. Among authors: patnaik r. Prog Brain Res. 2020;258:285-367. doi: 10.1016/bs.pbr.2020.09.004. Epub 2020 Nov 9. Prog Brain Res. 2020. PMID: 33223037 Review.
Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the rat.
Sharma HS, Muresanu DF, Patnaik R, Stan AD, Vacaras V, Perju-Dumbrav L, Alexandru B, Buzoianu A, Opincariu I, Menon PK, Sharma A. Sharma HS, et al. Among authors: patnaik r. J Nanosci Nanotechnol. 2011 Sep;11(9):7549-69. doi: 10.1166/jnn.2011.5114. J Nanosci Nanotechnol. 2011. PMID: 22097459
Diabetes exacerbates nanoparticles induced brain pathology.
Lafuente JV, Sharma A, Patnaik R, Muresanu DF, Sharma HS. Lafuente JV, et al. Among authors: patnaik r. CNS Neurol Disord Drug Targets. 2012 Feb;11(1):26-39. doi: 10.2174/187152712799960808. CNS Neurol Disord Drug Targets. 2012. PMID: 22229323 Review.
Novel Treatment Strategies Using TiO2-Nanowired Delivery of Histaminergic Drugs and Antibodies to Tau With Cerebrolysin for Superior Neuroprotection in the Pathophysiology of Alzheimer's Disease.
Sharma A, Menon PK, Patnaik R, Muresanu DF, Lafuente JV, Tian ZR, Ozkizilcik A, Castellani RJ, Mössler H, Sharma HS. Sharma A, et al. Among authors: patnaik r. Int Rev Neurobiol. 2017;137:123-165. doi: 10.1016/bs.irn.2017.09.002. Epub 2017 Nov 6. Int Rev Neurobiol. 2017. PMID: 29132541 Review.
271 results